Atea Pharmaceuticals Statistics Share Statistics Atea Pharmaceuticals has 85.58M
shares outstanding. The number of shares has increased by 1.37%
in one year.
Shares Outstanding 85.58M Shares Change (YoY) 1.37% Shares Change (QoQ) 0.06% Owned by Institutions (%) 61.33% Shares Floating 64.31M Failed to Deliver (FTD) Shares 1,066 FTD / Avg. Volume 0.26%
Short Selling Information The latest short interest is 4.34M, so 5.07% of the outstanding
shares have been sold short.
Short Interest 4.34M Short % of Shares Out 5.07% Short % of Float 6.36% Short Ratio (days to cover) 12.21
Valuation Ratios The PE ratio is -1.68 and the forward
PE ratio is -1.98.
Atea Pharmaceuticals's PEG ratio is
-0.07.
PE Ratio -1.68 Forward PE -1.98 PS Ratio 0 Forward PS 48.4 PB Ratio 0.64 P/FCF Ratio -2.08 PEG Ratio -0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Atea Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 24.85,
with a Debt / Equity ratio of 0.
Current Ratio 24.85 Quick Ratio 24.85 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.01M Employee Count 56 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 925K Effective Tax Rate -0.55%
Stock Price Statistics The stock price has increased by 4.48% in the
last 52 weeks. The beta is 0.25, so Atea Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.25 52-Week Price Change 4.48% 50-Day Moving Average 3.45 200-Day Moving Average 3.18 Relative Strength Index (RSI) 42.26 Average Volume (20 Days) 405,572
Income Statement
Revenue n/a Gross Profit n/a Operating Income -192.95M Net Income -168.38M EBITDA -167.04M EBIT -167.46M Earnings Per Share (EPS) -2
Full Income Statement Balance Sheet The company has 64.7M in cash and 1.64M in
debt, giving a net cash position of 63.05M.
Cash & Cash Equivalents 64.7M Total Debt 1.64M Net Cash 63.05M Retained Earnings -364.22M Total Assets 439.96M Working Capital 411.96M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -135.5M
and capital expenditures 0, giving a free cash flow of -135.5M.
Operating Cash Flow -135.5M Capital Expenditures n/a Free Cash Flow -135.5M FCF Per Share -1.61
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
